Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Kidney International
Journal
Overview
Identity
Overview
Publication Venue For
The mystery of cherry red ultrafiltrate in continuous renal replacement therapy
. 99:270.
2021
Results of the CARDIA study suggest that higher dietary potassium may be kidney protective
. 98:187-194.
2020
The zinc fingers and homeoboxes 2 protein ZHX2 and its interacting proteins regulate upstream pathways in podocyte diseases
. 97:753-764.
2020
Avian erythroblastosis virus E26 oncogene homolog-1 (ETS-1) plays a role in renal microvascular pathophysiology in the Dahl salt-sensitive rat
. 97:528-537.
2020
TLR9 activation induces aberrant IgA glycosylation via APRIL- and IL-6–mediated pathways in IgA nephropathy
. 97:340-349.
2020
Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease
. 96:1030-1036.
2019
FGF23 and inflammation—a vicious coalition in CKD
. 96:813-815.
2019
SON haploinsufficiency causes impaired pre-mRNA splicing of CAKUT genes and heterogeneous renal phenotypes.
. 95:1494-1504.
2019
Health-related quality of life in glomerular disease
. 95:1209-1224.
2019
Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease
. 95:1253-1261.
2019
Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop
. 94:1053-1068.
2018
Secondary IgA nephropathy
. 94:674-681.
2018
Genome-wide association studies suggest that APOL1-environment interactions more likely trigger kidney disease in African Americans with nondiabetic nephropathy than strong APOL1–second gene interactions
. 94:599-607.
2018
FGF23 effects on the heart—levels, time, source, and context matter
. 94:7-11.
2018
A more direct way to measure glomerular albumin permeability—even in human glomeruli!
. 93:1035-1037.
2018
APOL1 nephropathy risk variants do not associate with subclinical atherosclerosis or left ventricular mass in middle-aged black adults
. 93:727-732.
2018
Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease
. 93:691-699.
2018
Race but not Hepatitis C co-infection affects survival of HIV
+
individuals on dialysis in contemporary practice
. 93:706-715.
2018
Expanding the use of hepatitis C–viremic kidney donors
. 92:1031-1033.
2017
Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease
. 92:1206-1216.
2017
APOL1 genetic variants are not associated with longitudinal blood pressure in young black adults
. 92:964-971.
2017
GlucoCEST magnetic resonance imaging in vivo may be diagnostic of acute renal allograft rejection
. 92:757-764.
2017
The Authors Reply
. 91:1256.
2017
Renal xenotransplantation: experimental progress and clinical prospects
. 91:790-796.
2017
Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease
. 91:711-719.
2017
Obesity increases the risk of end-stage renal disease among living kidney donors
. 91:699-703.
2017
Screening, diagnosis, and management of patients with Fabry disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference
. 91:284-293.
2017
Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy
. 91:235-243.
2017
Chronic massive pneumoperitoneum
. 90:1386.
2016
Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease
. 90:985-996.
2016
C-reactive protein promotes acute kidney injury via Smad3-dependent inhibition of CDK2/cyclin E
. 90:610-626.
2016
Deletion of mineralocorticoid receptors in smooth muscle cells blunts renal vascular resistance following acute cyclosporine administration
. 89:354-362.
2016
Ligand trap for the activin type IIA receptor protects against vascular disease and renal fibrosis in mice with chronic kidney disease
. 89:1231-1243.
2016
Loss of Glis2/NPHP7 causes kidney epithelial cell senescence and suppresses cyst growth in the Kif3a mouse model of cystic kidney disease
. 89:1307-1323.
2016
The MEST score provides earlier risk prediction in lgA nephropathy
. 89:167-175.
2016
Migrated intra-jejunal peritoneal dialysis catheter
. 88:1457.
2015
Cell-based immunosuppression in kidney transplantation: The value of non-human primate studies
. 88:1196-1197.
2015
Renal systems biology of patients with systemic inflammatory response syndrome
. 88:804-814.
2015
Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation
. 88:584-592.
2015
Appendiceal tissue confirmation of Fabry's disease
. 88:417.
2015
A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease
. 88:146-151.
2015
Autosomal-dominant polycystic kidney disease (ADPKD): Executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
. 88:17-27.
2015
Macrophage and epithelial cell H-ferritin expression regulates renal inflammation
. 88:95-108.
2015
Obesity, metabolic health, and the risk of end-stage renal disease
. 87:1216-1222.
2015
Should kidney donors be genotyped for APOL1 risk alleles?
. 87:671-673.
2015
The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease
. 87:692-697.
2015
Kidney transplant results in children: Progress made, but blacks lag behind
. 87:492-494.
2015
A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation
. 87:409-416.
2015
Ethical challenges with hemodialysis patients who lack decision-making capacity: Behavioral issues, surrogate decision-makers, and end-of-life situations
. 86:475-480.
2014
Factors influencing clinical outcome in patients with primary hyperoxaluria type 1
. 86:1074-1076.
2014
Kidney donors at increased risk? Additional studies are needed
. 86:650.
2014
Kidney xenotransplantation
. 85:265-275.
2014
Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar
. 86:819-827.
2014
The high cost of organ transplant commercialism
. 86:858-859.
2014
Predicting dialysis vascular access blood flow and diameter: Too much, too little, or just right
. 84:1076-1078.
2013
The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy
. 82:1284-1296.
2012
A reproducible mouse model of chronic allograft nephropathy with vasculopathy
. 82:1231-1235.
2012
Delayed ischemic preconditioning contributes to renal protection by upregulation of miR-21
. 82:1167-1175.
2012
Of veins, valves, and vascular access!
. 82:1236-1237.
2012
The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression
. 82:790-796.
2012
Regarding Maas's editorial letter on serum suPAR levels
. 82:492.
2012
In vivo regulation of the heme oxygenase-1 gene in humanized transgenic mice
. 82:278-291.
2012
Sodium nitrite protects against kidney injury induced by brain death and improves post-transplant function
. 82:304-313.
2012
Critical care nephrology: Management of acid-base disorders with CRRT
. 82:9-18.
2012
Sugars and alcohol: IgA-associated renal diseases in alcoholic cirrhosis
. 80:1252-1254.
2011
Hydrogen sulfide inhibits the calcification and osteoblastic differentiation of vascular smooth muscle cells
. 80:731-739.
2011
Elevated depressive affect is associated with adverse cardiovascular outcomes among African Americans with chronic kidney disease
. 80:670-678.
2011
Validation of the Oxford classification of IgA nephropathy
. 80:310-317.
2011
Warfarin-related nephropathy: Another newly recognized complication of an old drug
. 80:131-133.
2011
Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis
. 80:79-87.
2011
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
. 79:1370-1378.
2011
Mineralocorticoid receptor activation and blockade: An emerging paradigm in chronic kidney disease
. 79:1051-1060.
2011
Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury
. 77:708-714.
2010
Vitamin D deficiency and anemia in early chronic kidney disease
. 77:715-720.
2010
Sociodemographic factors contribute to the depressive affect among African Americans with chronic kidney disease
. 77:1010-1019.
2010
Genotype-phenotype correlation in primary hyperoxaluria type 1: The p.Gly170Arg AGXT mutation is associated with a better outcome
. 77:443-449.
2010
Acute kidney injury in sepsis: Questions answered, but others remain
. 77:485-487.
2010
Hydrogen: Another gas with therapeutic potential
. 77:85-87.
2010
Protective role of extracellular superoxide dismutase in renal ischemia/reperfusion injury
. 78:374-381.
2010
Renal CD14 expression correlates with the progression of cystic kidney disease
. 78:550-560.
2010
Response to Targeting hyperphosphatemia: Truth or dare
. 77:257.
2010
Simulation of real-time ultrasound-guided renal biopsy
. 78:705-707.
2010
The Oxford IgA nephropathy clinicopathological classification is valid for children as well as adults
. 77:921-927.
2010
The authors reply
. 77:930.
2010
The authors reply
. 77:743-744.
2010
A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease
. 76:705-716.
2009
The Oxford classification of IgA nephropathy: Pathology definitions, correlations, and reproducibility
. 76:546-556.
2009
The Oxford classification of IgA nephropathy: Rationale, clinicopathological correlations, and classification
. 76:534-545.
2009
Complications impair the usefulness and validity of the rat tail arteriovenous fistula model
. 76:916.
2009
Effect of conservative treatment on the renal outcome of children with primary hyperoxaluria type 1
. 76:767-773.
2009
Neutrophils in acute kidney injury: Not neutral any more
. 75:674-676.
2009
Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): Review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008)
. 75.
2009
Uromodulin storage disease
. 73:971-976.
2008
Overexpression of innate immune response genes in a model of recessive polycystic kidney disease
. 73:63-76.
2008
Prevalence and severity of disordered mineral metabolism in Blacks with chronic kidney disease
. 73:956-962.
2008
Response to 'Overexpression of complement-component genes in Han:SPRD rats a model of polycystic kidney disease'
. 73:1325.
2008
Vitamin D levels and early mortality among incident hemodialysis patients
. 72:1004-1013.
2007
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels
. 71:1148-1154.
2007
When to refer patients with chronic kidney disease for vascular access surgery: Should age be a consideration?
. 71:555-561.
2007
Emphysematous pyelonephritis
. 71:462-465.
2007
HOpe for contrast-induced acute kidney injury
. 72:907-909.
2007
Impact of obesity on arteriovenous fistula outcomes in dialysis patients
. 71:39-43.
2007
Refractory hyponatremia
. 71:79-82.
2007
Hydroxyproline ingestion and urinary oxalate and glycolate excretion
. 70:1929-1934.
2006
Puromycin aminonucleoside induces oxidant-dependent DNA damage in podocytes in vitro and in vivo
. 70:1962-1973.
2006
Immunofluorescence on pronase-digested paraffin sections: A valuable salvage technique for renal biopsies
. 70:2148-2151.
2006
Response to 'Ultrasound surveillance and graft patency' [11]
. 70:1376.
2006
Post-transplant hypophosphatemia: Tertiary 'Hyper-Phosphatoninism'?
. 70:1486-1494.
2006
Unraveling the relationship between macula densa cell volume and luminal solute concentration/osmolality
. 70:865-871.
2006
Response to p-Cresol for better or worse: But what are we measuring? [5]
. 70:232-233.
2006
Cellular mechanisms of WNK4-mediated regulation of ion transport proteins in the distal tubule
. 69:2116-2118.
2006
Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure
. 69:1806-1813.
2006
Unearthing uric acid: An ancient factor with recently found significance in renal and cardiovascular disease
. 69:1722-1725.
2006
Outcomes of thrombosed arteriovenous grafts: Comparison of stents vs angioplasty
. 69:934-937.
2006
Randomized comparison of ultrasound surveillance and clinical monitoring on arteriovenous graft outcomes
. 69:730-735.
2006
3-5 year longitudinal follow-up of pediatric patients after acute renal failure
. 69:184-189.
2006
Hemodialysis reduces inhibitory effect of plasma ultrafiltrate on LDL oxidation and subsequent endothelial reactions
. 69:144-151.
2006
Outcomes of tunneled femoral hemodialysis catheters: Comparison with internal jugular vein catheters
. 68:2886-2889.
2005
Questions about graft surveillance [3]
. 68:2401-2402.
2005
Prevalence of chronic kidney disease and anemia among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study: Baseline results
. 68:1427-1431.
2005
Racial differences in renal arteriolar structure in children with minimal change nephropathy
. 68:1154-1160.
2005
IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells
. 67:504-513.
2005
Dialysis dose and the effect of gender and body size on outcome in the HEMO Study
. 65:1386-1394.
2004
Hydrogen peroxide mediates FK506-induced cytotoxicity in renal cells
. 65:139-147.
2004
Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension
. 66:281-287.
2004
The impact of serum uric acid on cardiovascular outcomes in the LIFE study
. 65:1041-1049.
2004
Thrombospondin-1 is a major activator of TGF-β in fibrotic renal disease in the rat in vivo
. 65:459-468.
2004
Lipoproteins in the DCCT/EDIC cohort: Associations with diabetic nephropathy
. 64:817-828.
2003
Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort
. 64:1035-1045.
2003
The FcγRIIIA-F158 allele is a risk factor for the development of lupus nephritis: A meta-analysis
. 63:1475-1482.
2003
Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients
. 63:346-352.
2003
Sodium ferric gluconate complex in hemodialysis patients. Ii. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients
. 63:217-224.
2003
Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions.
. 62:1109-1124.
2002
Increasing arteriovenous fistulas in hemodialysis patients: Problems and solutions
. 62:1109-1124.
2002
Interactions of human mesangial cells with IgA and IgA-containing immune complexes
. 62:465-475.
2002
Novel erythropoiesis-stimulating protein in the management of the anemia of chronic renal failure
. 62:720-729.
2002
Sodium ferric gluconate complex in hemodialysis patients: Adverse reactions compared to placebo and iron dextran
. 61:1830-1839.
2002
Contribution of dietary oxalate to urinary oxalate excretion
. 59:270-276.
2001
Cytochrome c mediates apoptosis in hypertensive nephrosclerosis in Dahl/Rapp rats
. 59:662-672.
2001
Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients
. 60:2013-2020.
2001
Increased dietary salt accelerates chronic allograft nephropathy in rats
. 59:1149-1157.
2001
Nitric oxide and Bartter and Gitelman syndromes
. 60:1197-1198.
2001
Simplified citrate anticoagulation for continuous renal replacement therapy
. 60:370-374.
2001
Factors associated with the prevalence of arteriovenous fistulas in hemodialysis patients in the HEMO study. Hemodialysis (HEMO) Study Group.
. 58:2178-2185.
2000
Arteriovenous fistula adequacy [3] (multiple letters)
. 57:347-348.
2000
Bacteremia associated with tunneled dialysis catheters: Comparison of two treatment strategies
. 57:2151-2155.
2000
Factors associated with the prevalence of arteriovenous fistulas in hemodialysis patients in the HEMO study
. 58:2178-2185.
2000
Induction of apoptosis during development of hypertensive nephrosclerosis
. 58:2007-2017.
2000
Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study
. 58:1703-1710.
2000
Dynamics of E-cadherin and γ-catenin complexes during dedifferentiation of polarized MDCK cells
. 56:910-921.
1999
Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure
. 55:2423-2432.
1999
Predictors of adequacy of arteriovenous fistulas in hemodialysis patients
. 56:275-280.
1999
Regulation of endosomal acidification via G
1
-type protein
. 55:2524-2525.
1999
Thrombospondin peptides are potent inhibitors of mesangial and glomerular endothelial cell proliferation in vitro and in vivo
. 55:2236-2249.
1999
A multidisciplinary approach to hemodialysis access: Prospective evaluation
. 53:473-479.
1998
Dietary salt regulates expression of Tamm-Horsfall glycoprotein in rats
. 54:1150-1156.
1998
Liddie syndrome: An autosomal dominant form of human hypertension
. 53:18-24.
1998
Regulation of macula densa Na:H exchange by angiotensin II
. 54:2021-2028.
1998
Antibodies to C1q in systemic lupus erythematosus: Characteristics and relation to FcγRIIA alleles
. 52:1375-1380.
1997
Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG
. 52:509-516.
1997
Glomerular and vascular tissues do not down-regulate nitric oxide synthesis during protracted endotoxemia
. 52:460-467.
1997
Altered sodium-calcium exchange in afferent arterioles of the spontaneously hypertensive rat
. 50:1889-1896.
1996
Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy
. 49:571-577.
1996
Characterization of sodium-calcium exchange in rabbit renal arterioles
. 50:1856-1862.
1996
Diversity and regulation of amiloride-sensitive Na
+
channels
. 49:1632-1637.
1996
Functional correction of renal defects in a mouse model for ARPKD through expression of the cloned wild-type Tg737 cDNA
. 50:1240-1248.
1996
Isolation and characterization of luminal and basolateral plasma membrane vesicles from the medullary thick ascending loop of Henle
. 50:1051-1057.
1996
Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria
. 49:244-250.
1996
cAMP-regulated trafficking of epitope-tagged CFTR
. 49:1642-1648.
1996
Activation of Na:2Cl:K cotransport by luminal chloride in macula densa cells
. 47:752-757.
1995
Evidence for apical sodium proton exchange in macula densa cells
. 47:746-751.
1995
Induction of heme oxygenase in toxic renal injury: A protective role in cisplatin nephrotoxicity in the rat
. 48:1298-1307.
1995
Adaptive control of anticoagulation during hemodialysis
. 45:912-915.
1994
Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis
. 46:1397-1403.
1994
Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia
. 43:212-217.
1993
Relationship of protein intake to urinary oxalate and glycolate excretion
. 44:366-372.
1993
Shared idiotypes in mesangial deposits in IgA nephropathy are not disease-specific
. 44:65-74.
1993
Treatment and prevention of hyperkalemia in end-stage renal disease
. 43:1197-1209.
1993
Binding of serum immunoglobulins to collagens in IgA nephropathy and HIV infection
. 42:374-382.
1992
Adrenergic modulation of extrarenal potassium disposal in men with end-stage renal disease
. 40:1103-1109.
1991
Communication between the macula densa cells and the afferent arteriole
1991
Determinants of renal microvascular autoregulatory behavior in normal and hypertensive rats
1991
IgA nephropathy in blacks: Studies of IgA2 allotypes and clinical course
. 39:1218-1224.
1991
OKT3 first-dose reaction: Association with T cell subsets and cytokine release
. 39:141-148.
1991
Transport pathways in macula densa cells
1991
Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients
. 38:869-872.
1990
Insulin in the acute renal adaptation to dietary phosphate restriction in the rat
. 37:14-20.
1990
Control of serum potassium during fasting in patients with end-stage renal disease
. 35:90-94.
1989
K-Cl cotransport systems
. 36:412-417.
1989
Angiotensin influences on tubuloglomerular feedback mechanism in hypertensive rats
. 34:631-637.
1988
Effects of nonsteroidal antiinflammatory drugs on renal function in sickle cell anemia
. 34:500-506.
1988
Morphologic alterations of the proximal tubules in light chain-related renal disease
. 33:881-889.
1988
Uremic acidosis
. 34:278-287.
1988
Complement activation in IgA nephropathy
. 31:1019-1023.
1987
Human Bence Jones protein toxicity in rat proximal tubule epithelium in vivo
. 32:851-861.
1987
The sympathetic nervous system in clinical and experimental hypertension
. 30:437-452.
1986
Cyclic AMP-calcium interaction in the transmission of tubuloglomerular feedback signals
. 28:728-732.
1985
Effect of urinary pH and diatrizoate on Bence Jones protein nephrotoxicity in the rat
. 27:46-50.
1985
Complement phenotypes in glomerulonephritis: Increased frequency of homozygous null C4 phenotypes in IgA nephropathy and Henoch-Schonlein purpura
. 26:855-860.
1984
Dialysis-associated ischemic heart disease: Insights from coronary angiography
. 25:653-659.
1984
Carbohydrate metabolism during fasting in chronic hemodialysis patients
. 24:222-226.
1983
Accelerated recovery of single nephron function by the postischemic infusion of ATP-MgCl
2
. 22:13-20.
1982
Acidification in the in vitro perfused tubule
. 22:507-518.
1982
Luminal and cellular mechanisms for the mediation of tubuloglomerular feedback responses
. 22.
1982
Relationship between tubulo-glomerular feedback responses and perfusate hypotonicity
. 22:234-239.
1982
Relationship of coronary risk factors to hemodialysis-associated ischemic heart disease
. 22:304-308.
1982
Role of a macula densa feedback mechanism as a mediator of renal autoregulation
. 22.
1982
Enhanced recovery from acute renal failure by the postischemic infusion of adenine nucleotides and magnesium chloride in rats
. 17:338-349.
1980
Impaired renal blood flow autoregulation in ischemic acute renal failure
. 18:68-76.
1980
Tubuloglomerular feedback responses during perfusion with nonelectrolyte solutions in the rat
. 18:460-471.
1980
Glomerular filtration dynamics in the dog during elevated plasma colloid osmotic pressure
. 15:502-512.
1979
Ischemic heart disease in patients with uremia undergoing maintenance hemodialysis
. 16:600-611.
1979
Renal tubular transport and catabolism of proteins and peptides
. 16:271-278.
1979
Effects of acetazolamide (ACTZ) on total CO
2
reabsorption in the rat
. 14:753.
1978
Influence of vasodilators on glomerular filtration dynamics in the dog
. 14:772.
1978
Accelerated recovery of acute renal failure by infusion of adenine nucleotides - MgCl
2
. 12:534.
1977
Dual effects of diuretics on volume reabsorption by the proximal tubule
. 12:566.
1977
Evaluation of the single nephron glomerular filtration coefficient in the dog
. 12:137-149.
1977
Possible role of osmolality in the mediation of the distal tubular-glomerular feedback responses in the dog
. 12:568.
1977
Identity
International Standard Serial Number (issn)
0085-2538
Electronic International Standard Serial Number (eissn)
1523-1755